25
Participants
Start Date
February 28, 2006
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2010
Trastuzumab
Trastuzumab will be administered as an 8 mg/kg loading dose by intravenous (IV) infusion over 90 minutes on day 1 of cycle 1. Subsequent doses will be administered as a 6 mg/kg IV dose over 30 minutes.
Oxaliplatin
"Oxaliplatin will be administered at a dose of 130 mg/ m2 over 120 minutes on day 1 of each cycle, following standard antiemetic premedications. 21 day cycles.~For the first cycle, trastuzumab will be administered before oxaliplatin; however for subsequent cycles, oxaliplatin will be infused prior to trastuzumab"
Spartanburg Regional Medical Center, Spartanburg
Tennessee Oncology, PLLC, Nashville
Chattanooga Oncology and Hematology Associates, Chattanooga
Graves-Gilbert Clinic, Bowling Green
Oncology Hematology Care, Cincinnati
Baton Rouge General Medical Center, Baton Rouge
Hematology Oncology Life Center, Alexandria
Collaborators (1)
Sanofi
INDUSTRY
SCRI Development Innovations, LLC
OTHER